doi:10.1016/j.jad.2025.119670 31
3192104.e5
Recalls & Warnings November 29, 2019 FDA Warns Seller of "All Natural" Treatment for Opioid Withdrawal, Migraines & More On November 18, 2019, the FDA issued a warning letter to EPH Technologies, Inc., following a review of the company's websites, which found statements made about some of the company's products, including Detoxoplex, Sinople, and Migrenz, to be drug claims
Aim for at least eight glasses of water daily during the first month, more if you are experiencing diarrhea
A spinoff company, Athira Pharma (formalized as M3 Biotechnology before rebranding), was founded in 2011 by PhD student Leen Kawas to commercialize dihexa and a related molecule, ATH-1017 (fosgonimeton)
Canadian pharmacy brands undergo review ensuring bioequivalence to reference products, though individual response to vehicle ingredients like propylene glycol varies